Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anne Evans Kingston currently holds 100,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA), valued at approximately $0. This represents their equity stake as Chief Strategy Officer.
Based on SEC Form 4 filings, Anne Evans Kingston has been a net neutral trader of PRTA stock. They have purchased $0 and sold $0 worth of shares.
Anne Evans Kingston's most recent insider trade was on Apr 10, 2026, when they sold 100,000 shares at $0.00 per share.
Anne Evans Kingston serves as Chief Strategy Officer at PROTHENA CORP PUBLIC LTD CO (PRTA). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Anne Evans Kingston holds the position of Chief Strategy Officer at PROTHENA CORP PUBLIC LTD CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Anne Evans Kingston has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Anne Evans Kingston was on Apr 10, 2026, when they purchased $0 worth of PRTA shares. This transaction involved 100,000 shares at N/A per share.
Anne Evans Kingston currently owns 100,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anne Evans Kingston's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anne Evans Kingston has 1 Form 4 filings on record as an insider at PROTHENA CORP PUBLIC LTD CO.
Set alerts for Anne Evans Kingston and 40,000+ other insiders.